Navigation Links
Growth of Mice Model Industry (Oncology, Immunology, CNS) with 2018 Forecasts in a New Research Report at RnRMarketResearch.com
Date:1/8/2014

Dallas, Texas (PRWEB) January 08, 2014

Over the years, the mice model market, which includes models and services, has witnessed many innovations that have led to an increase in the application areas of mice models. For instance, mice models are widely used in preclinical research in a number of academic institutions all around the world and also in various industries including pharmaceutical, biotechnology, biopharmaceutical, medical research, biomedical research, and others.

The inbred mice market is the fastest-growing segment of the mice model market. The rapid growth of this market is attributed to their ability to reproduce the same results in different laboratories over a period of time. However, the knockout mice model market is the fastest-growing market due to the increase in the number of investments in the development of knockout mice models. One of the major investments includes $110 million by the National Institutes of Health (NIH) (U.S.) for a period of five years to initiate the second phase of the Knockout Mouse Project (KOMP2) in September 2011.

Complete report available @ http://www.rnrmarketresearch.com/mice-model-market-by-type-inbred-knockout-conditioned-technology-microinjection-embryonic-stem-cell-disease-oncology-immunology-cns-service-breeding-cryopreservation-quarantine-c-market-report.html.

In the mice model services market, the breeding market is expected to grow at the highest CAGR. This is due to the increase in the production of mice as well as the increase in use of mice by companies, which has increased the need to manage the breeding of these mice in an effective manner. Thus, the growing market for mice models is likely to boost the market for breeding services.

In the coming years, the growth of the mice model market is likely to be focused on China, India, Japan, Brazil, and Mexico. These countries offer a wide array of opportunities for growth and are likely to serve as revenue pockets for the mice model market. All these countries offer high-growth potential as compared to mature markets such as the U.S. and U.K.

Growth in these markets is spurred by the growing R&D activities in China, Japan, Brazil, and Singapore. In addition to this, the Asian countries have low presence of animal welfare activities conducted by animal activists and thus are potential regions to outsource animal models and allied animal testing services. Thus, the Asian region is more adaptive and business friendly due to the comparatively less stringent regulations. This has led to an increase in R&D activities in this region. The region is a hub for preclinical trials and has witnessed a high growth in the CRO industry in China, India, Korea, and Taiwan. According to ClinicalTrials.gov, the number of clinical trials conducted in India was 40 to 50 in 2003, which increased to 270 by 2007. China, on the other hand, surpassed India and showcased 428 ongoing trials in 2008 and a total of 870 trials (including completed and ongoing) as compared to 737 trials in India by 2008. Additionally, clinical trials are expected to be up to 50% cheaper in India compared to the U.S. Thus, the growth in R&D activities is propelling the demand for mice models.

The mice model market is highly competitive and has few major companies dominating the market. Players operating in the market strive hard to gain market visibility and a larger market share. Companies primarily focus on strategies such as agreements, partnerships, collaborations, joint ventures, and mice model out-licensing in order to increase their customer base. However, the stringent laws and regulations for the ethical use of laboratory animals are limiting the use of these mice models.

The report extensively covers mice models and services and mice care products used in a number of life sciences industries. Volume analysis of the market has not been provided due to wide variations in prices of mice models, which vary with different indications.

Major points from table of content

8 Company Profiles
8.1 Ablexis, LLC
8.2 Charles River Laboratories, Inc.
8.3 Covance, Inc.
8.4 Crescendo Biologics,
8.5 Deltagen, Inc.
8.6 Genoway Sa
8.7 Harbour Antibodies Bv
8.8 Harlan Laboratories, Inc.
8.9 Immunogenes Ag
8.1 Ingenious Targeting Laboratory
8.11 Lexicon Pharmaceuticals, Inc.
8.12 Mirimus, Inc.
8.13 Taconic Farms, Inc.
8.14 The Jackson Laboratory
8.15 Transgenic, Inc.
8.16 Sage Labs

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=140183.

Browse more reports on Veterinary Health Market Reports @ http://www.rnrmarketresearch.com/reports/life-sciences/healthcare/veterinary-health.

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/2018-mice-model-market/analysis-and-forecast/prweb11468519.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Moffitt Cancer Center researchers identify drivers of sarcoma growth and survival
2. Low oxygen levels could drive cancer growth
3. Report using private health claims data shows prices are driving health spending growth
4. Mutations impair childhood growth and development by disrupting organization of chromosome pairs
5. Disease that stunts infants growth traced to same gene that makes kids grow too fast
6. Scientists discover mechanism that promotes lung cancer growth and survival
7. Nerve growth factors elevated in pancreatic cancer model
8. Exercise Wont Affect Breast Milk, Babys Growth: Study
9. QTrade's New Facility Anticipates Dramatic Growth of Tea Industry
10. Rising Solar Engineering and Design Firm Enters 1.7 MW's in Connecticut ZREC Auction and Positions for Future Growth
11. Mahvrick Expands to Brazil, Russia, India, China to Support Existing Client Customer Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... The Pennsylvania Athletic ... (PCN) during the summer of 2016. The program was made possible by a ... States Department of Health and Human Services Administration. The broadcast, Use Your ...
(Date:12/8/2016)... ... 08, 2016 , ... Russ DiGilio , founder and ... #QuackGivesBack campaign which supported local breast cancer organizations during National Breast Cancer Awareness ... Back initiative, and we’re very pleased with the participation in every franchisee’s ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital ... aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media ... Jr said, “CURE Media Group is honored to team up with Upstage Lung Cancer ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... ... STAT courier is pleased to announce that due to customer demand, as ... their presence in Dallas. One of the most exciting parts for STAT is that ... Dallas and Forth Worth market. STAT takes pride in treating their employees with integrity ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  The global biosurgery market is ... the forecast period of 2016 to 2021. The market ... from USD 18.21 billion in 2016. The market is ... of sports related injuries and spinal problems, increasing clearance ... of effective blood loss management. In this ...
(Date:12/8/2016)... -- KEY FINDINGS North America ... in 2016 and is expected to continue in the ... large number of surgical procedures that are taking place ... the patient temperature management market.) Patient warming and cooling ... blood during surgeries, lowering the risks of neurological disorders ...
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and Company ... of its phase 3 EXPEDITION3 trial at the 9 ... As previously disclosed, solanezumab did not meet the primary ... solanezumab initiated in people with mild dementia due to ... submissions for solanezumab for the treatment of mild dementia ...
Breaking Medicine Technology: